ALBERTO GONZALEZ: Open Payments
NPI 1487677696 · ORANGEBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 44 payments from 11 companies in 2025. Trend: 2023 $430 · 2024 $900 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $175 |
| Otsuka America Pharmaceutical, Inc. | 10 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| Almatica Pharma LLC | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $34 |
| Bausch Health US, LLC | 1 | $32 |
| Indivior Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, LOREEV XR, Jornay PM, APLENZIN, ABILIFY ASIMTUFII.
Industry payments across SC — which companies pay providers there.
